Combined company will operate under the name “TuHURA Biosciences, Inc.” and advance a personalized cancer vaccine platform and preclinical tumor microenvironment modulators Lead asset, IFx-Hu2.0, ...
TAMPA, FL / ACCESSWIRE / October 19, 2016 / Morphogenesis, Inc., a biotechnology company headquartered in Tampa, FL, announces its plans to raise up to $20 million from the sale of its common stock to ...
TAMPA, FL / ACCESSWIRE / November 8, 2023 / Morphogenesis, Inc. ("Morphogenesis"), a privately-held Phase 3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor ...
Privately-held Morphogenesis Inc has agreed to combine with CohBar Inc CWBR in an all-stock transaction forming a company combining expertise and resources to advance a late-stage oncology pipeline.
THE discussion on morphogenesis which was held in Section D (Zoology) during the Blackpool meeting of the British Association was concerned mainly with the use of the field concept in experimental ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback